Author:
Chin Chih-Liang,Carr Robert A.,Llano Daniel A.,Barret Olivier,Xu Hongyu,Batis Jeffrey,Koren Andrei O.,Seibyl John P.,Marsh Kennan C.,Tamagnan Gilles,Decker Michael W.,Day Mark,Fox Gerard B.
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Subject
Pharmacology,Molecular Medicine
Reference40 articles.
1. Bain E Apostol G Sangal RB Robieson WZ Abi-Saab WM Saltarelli M (2009) Safety and efficacy of ABT-089, a novel α4β2 neuronal nicotinic receptor partial agonist, in the treatment of adults with attention-deficit/hyperactivity disorder, 56th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, abstract 3.3; 2009 Oct 27–Nov 1; Honolulu, Hawaii. American Academy of Child and Adolescent Psychiatry, Washington, DC.
2. Chemical fate of the nicotinic acetylcholinergic radiotracer [123I]5-IA-85380 in baboon brain and plasma
3. Further studies on nicotine-induced emesis: Nicotinic mediation in area postrema
4. In vivo imaging of brain nicotinic acetylcholine receptors with 5-[123I]iodo-A-85380 using single photon emission computed tomography
5. ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys;Decker;J Pharmacol Exp Ther,1997
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献